News & Articles

A study by Karl Landsteiner University of Health Sciences shows that higher radiation doses in lung cancer treatment carry no added risk of inflammation and may improve survival

New solutions support high-precision analytics for process development, batch release and regulatory compliance and enable a standardized workflow

1 in 3 Phase II trials were terminated in 2024

The UG 100 offers a cost-effective and extremely low-error sequencing profile

Dive into a new era of intelligence and performance with Agilent's upcoming virtual launch

Drug Discovery returns to Liverpool, 21–22 October 2025 to celebrate 'A Festival of Life Science'

The Adeno-Associated Virus will be used in a Phase 1 trial in patients with advanced, high-risk acute myeloid leukemia.

New test format enhances commercialisation potential

Since 2021, only 14% of rivers in England achieved ‘good’ ecological status and none received an overall ‘good’ classification from the Environment Agency

The VENTANA TROP2 (EPR20043) RxDx Device is an immunohistochemistry (IHC) assay combined with a digital pathology algorithm to determine patient treatment

Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform

Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale

Bruker and RECIPE are pioneering the high-throughput ‘chrom-free’ ClinDART triple-quad MS platform for robust and cost-effective therapeutic drug monitoring assays

Innovative 6,000-square-foot facility enables clinical and commercial process development support to help cell therapy developers transition from research-scale to commercialization

Explore streamlined navigation, personalized recommendations, and expert support for preclinical products and research services.

The partnership aims to deliver instruments, reagents, and consumables to service laboratories, breeders, and researchers worldwide.

Poster explores BOLD-100's unique ability to mitigate oxaliplatin-induced peripheral neuropathy (OIPN)

Hungarian researchers have published their latest findings in the prestigious international journal Biomedicines. They show that deuterium depletion, when used as a complementary therapy in cancer treatment, can significantly increase patient survival rates and reduce cancer-related mortality by 75-80%.

Aggregate analysis of eight clinical trials of patients with advanced non-small cell lung cancer (aNSCLC) was supported by Biodesix, using Bio-Rad Droplet Digital PCR technology

Scientists warn of major risks to food security and public health as soil pollution spreads worldwide

Two ELISA kits for diagnostics and two for research